ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,875Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 95

$1.87M Total Retail Price of All Prescriptions

Rank: 1 out of 95

539 Patients Receiving at Least One Drug in Part D
15%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 539 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

5% of this provider’s 1,765 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$145 was the average price of a prescription from this provider, compared to $133 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
CLOZAPINE 701 46 1 16
GABAPENTIN 531 73 2 23
TRAZODONE HCL 512 13 3 1
SERTRALINE HCL 469 65 4 9
HALOPERIDOL 415 67 5 19
BENZTROPINE MESYLATE 412 20 R 6 5
DIVALPROEX SODIUM ER 381 84 7 10
HALOPERIDOL DECANOATE 379 44 10 8 33
CYMBALTA 363 68 9 11
LAMOTRIGINE 324 0 10 12
BUPROPION XL 305 84 11 14
INVEGA SUSTENNA 302 23 12 31
LATUDA 290 50 13 46
ABILIFY 271 22 14 7
FLUOXETINE HCL 249 14 15 8
LITHIUM CARBONATE 244 22 16 13
NAMENDA 201 71 17 39
SEROQUEL XR 193 15 18 27
RISPERIDONE 192 16 19 2
TOPIRAMATE 175 28 20 24
OLANZAPINE 172 16 21 15
ESCITALOPRAM OXALATE 166 29 22 20
ZOLPIDEM TARTRATE 158 0 23 3
MIRTAZAPINE 149 27 24 17
SIMVASTATIN 143 50 25 69
BUSPIRONE HCL 136 16 26 25
ZIPRASIDONE HCL 133 0 27 26
RISPERDAL CONSTA 128 0 28 32
MELOXICAM 121 37 29 73
PROPRANOLOL HCL 120 24 30 38
FAMOTIDINE 112 12 31 74
OMEPRAZOLE 111 0 32 60
ROPINIROLE HCL 107 0 33 75
PAROXETINE HCL 107 0 33 22
LOXAPINE 107 23 33 56
FLUPHENAZINE HCL 105 25 36 50
PINDOLOL 99 0 37 77
LEVOTHYROXINE SODIUM 89 11 38 54
CITALOPRAM HBR 89 0 38 4
LISINOPRIL 88 12 40 80
SAPHRIS 84 17 41 69
PERPHENAZINE-AMITRIPTYLINE 78 29 R 42 68
GEODON 77 0 43 71
METOPROLOL TARTRATE 75 0 44 82
NEXIUM 71 11 45 86
STRATTERA 70 0 46 87
VENLAFAXINE HCL 68 22 47 36
HALOPERIDOL DECANOATE 100 67 0 48 63
CLONIDINE HCL 62 0 49 66
QUETIAPINE FUMARATE 62 0 49 6
DIVALPROEX SODIUM 62 0 49 37
LUNESTA 60 0 52 52
METFORMIN HCL 58 0 53 91
POTASSIUM CHLORIDE 56 30 54 93
TRIHEXYPHENIDYL HCL 53 23 R 55 29
PHENYTOIN SODIUM EXTENDED 51 15 56 96
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 27, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.